Treace Medical Concepts (NASDAQ: TMCI) — Perfil da empresa, notícias e dados financeiros
Treace Medical Concepts is innovating orthopedics focusing on the Lapiplasty® 3D Bunion Correction™ system for foot and ankle surgery.
Treace Medical Concepts
Treace Medical Concepts (NASDAQ:TMCI) is dedicated to innovating the field of orthopedics, focusing primarily on foot and ankle surgery solutions. The company is well-known for its pioneering Lapiplasty® 3D Bunion Correction™ system, which represents a significant advancement in treating bunion deformities by realigning and securing the foundational bone. Treace Medical Concepts aims to enhance surgical outcomes while reducing recovery times for patients. Alongside the development and marketing of cutting-edge medical devices, the company is deeply invested in clinical research to support the efficacy and safety of its products. Achieving operational excellence and expanding its product portfolio to address a wider range of orthopedic issues remain central to its objectives, with a strong commitment to improving patient quality of life through surgical innovation.
Resumo
Operações
Produtos e/ou serviços de Treace Medical Concepts
- Lapiplasty® 3D Bunion Correction® System: This is a patented surgical system designed to address bunion deformities at the root cause. It involves a combination of instruments, implants, and surgical techniques that aim to correct the bunion deformity in all three planes (frontal, transverse, and sagittal).
equipe executiva do Treace Medical Concepts
- John T. TreaceFounder, Chairman & CEO
- Mark L. HairChief Financial Officer
- Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary
- Sean F. ScanlanChief Innovation & Marketing Officer
- Terry W. LubbenChief Operations & Supply Chain Officer
- Zac PotterSenior VP & Chief Accounting Officer
- Taylor EricksonChief Information & Cybersecurity Officer
- Brad BarrSenior Vice President of Sales
- Daniel E. OwensChief Human Resources Officer
- Shana ZinkSenior Vice President of Clinical Affairs & Reimbursement
Últimas notícias sobre a Treace Medical Concepts
Principais indicadores financeiros
Resultados divulgados pela Treace Medical Concepts, em USD.
- Cap. de mercado
- 314,1 mi
- Receita (TTM)
- 205,3 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.9
- Dividend yield
- —
- Margem de lucro
- -29.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 212,7 mi | -54,2 mi | -59 mi | |
| 209,4 mi | -55,7 mi | -55,7 mi | |
| 187,1 mi | -51,4 mi | -49,5 mi | |
| 141,8 mi | -34,8 mi | -42,8 mi |